the EU has extended the approved uses of Roche's antiviral Xofluza to include treatment and prevention in very young children. The label for Xofluza (baloxavir marboxil) has been extended to ...

Roche’s new influenza drug Xofluza can dramatically prevent the spread of the virus when used as a preventive therapy, according to new phase 3 data. Xofluza (baloxavir marboxil) is already ...

Roche RHHBY announced positive top-line results from a late-study on influenza drug, Xofluza. The CENTERSTONE study was a global phase III trial investigating the efficacy of single-dose Xofluza ...